•  
  •  
 

Abstract

Abstract Background: Prostatic Specific Antigen (PSA) is considered the most dependent tumor marker of carcinoma of prostate. It is considering organ-specific tumor marker but not disease specific. It is the most prevalent screening tool for carcinoma of prostate and most proportion of prostatic carcinoma are diagnosed with prostatic biopsy when there is abnormally elevated level of serum PSA. Aim of study: Our research study aimed to define the relationship of BMI (body mass index ) as a marker of obesity with serum PSA level and their correlation to age and prostatic volume.Patients and methods: Our study involved 115 cases with their age was more than 55 years. In 35 cases, their age was between 55 and 59 years, in 53 cases their age was between 60 to 69 years, and in 27 cases, the age was above 70 years. Their BMI categorized into 3 groups: group 1 include obese people (BMI > 27kg/m2) which includes 55 cases, group 2 overweights (BMI 23- 27 kg/m2) which include 37 cases, and group 3 includes normal weights (BMI 18.5 - 23kg/m2) which include 23 cases. Body mass index, total serum PSA and volume of prostate were measured for every case in this research and the results are analyzed statistically by using IBM-SPSS 26. A P-value ≤ 0.05 deemed significant for this study. Results: Obese individuals exhibited significantly lower median serum PSA in comparison to overweight and normal BMI males 1.6, 2.2, 2.69 ng/ml, in group 1, group 2, and group 3 respectively. There is a considerable significantly negative correlation of PSA with BMI (Spearman’s coefficient= -0396, p=0.001). Also, there was no statistically significant variation found between the groups regarding prostate size (p = 0.532). There was a positive correlation of serum PSA with the age (r= 203, p = 0.029).

DOI

10.52573/ipmj.2025.144784

Download

Share

COinS